Popular Articles From: Rayonier Appoints Douglas Long as Vice President of U.S. Operations to Platts: Global Petrochemical Prices Fell 3% in September


Rayonier Inc. (NYSE: RYN) today announced that Douglas Long, Director, Atlantic Region, U.S. Forest Resources, has been appointed to the newly created position of Vice President, U.S. Operations, effective immediately.
Sign-up for Rayonier Appoints Douglas Long as Vice President of U.S. Operations investment picks
Rayonier Advanced Materials Inc. (NYSE:RYAM) announced today that the company’s board of directors has declared a fourth quarter cash dividend of $0.07 per share of common stock of the corporation.
Sign-up for Rayonier Advanced Materials Announces Fourth Quarter 2014 Dividend investment picks
Global Net Product Sales for PROCYSBI ® of $23.8 Million for Third Quarter 2014 PROCYSBI Revenue of $52.2 Million Reached Through September 2014 PROCYSBI Revenue Guidance of $65-$70 Million Maintained 2014 Cash Operating Expense Guidance Narrowed to $80-$85 Million NOVATO, Calif., Nov.
Sign-up for Raptor Pharmaceutical Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
NOVATO, Calif., Oct.
Sign-up for Raptor Pharmaceutical Announces Management Changes investment picks
NEW YORK, Nov.
Sign-up for Rand Logistics Announces Additional Organizational Changes investment picks
MAHWAH, N.J., Sept.
Sign-up for Radware Provides Customers Protection From Bash Bug Shellshock Vulnerability investment picks
- Control Software Agreement to provide Quantum with more than $5.0 million over the coming year - Control software license to cover Fisker Karma and Atlantic series with option for joint-ownership for these and other future platforms LAKE FOREST, Calif.
Sign-up for Quantum Technologies Enters into License Agreement with Fisker Automotive and Technologies Group LLC to provide Plug-In Hybrid Control Software to Support Re-Launch of the Fisker Karma Vehicle investment picks
http://media.marketwire.com/attachments/201408/267133_vert_2C_logo_tag_eps.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158551&ProfileId=051205&sourceType=1 REDWOOD CITY, CA --
Sign-up for Qualys Wins Three Information Security(TM) Magazine and SearchSecurity.com 2014 Readers' Choice Awards for Risk Policy Management, Vulnerability Management and Application Security investment picks
Qualcomm Inc. (QCOM) on Wednesday reported a fiscal fourth-quarter profit of $1.89 billion, or $1.11 a share, on revenue of $6.69 billion.
Sign-up for Qualcomm shares fall 4% as results miss expectations investment picks
NEW YORK, Oct.
Sign-up for PwC and Google Announce Joint Business Relationship investment picks
-First drug for the underlying cause of nonsense mutation Duchenne muscular dystrophy - SOUTH PLAINFIELD, N.J. , Dec.
Sign-up for PTC Therapeutics Announces Launch of Translarna™ (ataluren) in Germany investment picks
Prudential Investments ® has launched the Prudential Income Builder Fund (NASDAQ:PCGAX), a fund that offers investors the potential for income and long-term capital growth by investing primarily in income-focused equity, fixed income and non-traditional investments.
Sign-up for Prudential Investments launches Prudential Income Builder Fund investment picks
Prudential Financial, Inc. (NYSE:PRU): • Prudential Financial, Inc. (NYSE:PRU) today reported after-tax adjusted operating income for its Financial Services Businesses of $1.034 billion ($2.20 per Common share) for the third quarter of 2014, compared to $1.373 billion ($2.89 per Common share) for the year-ago quarter.
Sign-up for Prudential Financial, Inc. Announces Third Quarter 2014 Results investment picks
Prudential Financial, Inc. (NYSE:PRU) announced today that it has named Naveen Agarwal to the newly created position of Vice President and Chief Customer Officer.
Sign-up for Prudential Financial names Naveen Agarwal chief customer officer investment picks
Prudential Annuities , the domestic annuity business for Prudential Financial, Inc. (NYSE:PRU), today announced a new asset allocation portfolio available with its Prudential Premier Retirement variable annuities that offer the Highest Daily Lifetime Income v3.0 benefit.
Sign-up for Prudential Annuities adds fund to leading investment lineup investment picks
Proto Labs, Inc. (NYSE:PRLB), a leading online and technology-enabled quick-turn manufacturer, today announced financial results for the third quarter ended September 30, 2014.
Sign-up for Proto Labs Reports Record Revenue for the Third Quarter 2014 investment picks
http://media.marketwire.com/attachments/200805/430382_ProspectCapitalLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157045&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Earns $0.44 of Taxable Income per Share for September Quarter and Announces Intention to Unlock Value by Spinning off "Pure Play" Business Strategies to Shareholders investment picks
LINDON, Utah, Aug.
Sign-up for Profire Energy to Unveil New Warehouse at Annual Meeting on September 18, 2014 investment picks
LINDON, Utah, Sept.
Sign-up for Profire Energy to Ring NASDAQ Closing Bell on Thursday, October 9 investment picks
Principal Financial Group, Inc. (NYSE:PFG) will release its outlook for 2015 before the market opens on Dec.
Sign-up for Principal Financial Group, Inc. to Host 2015 Outlook Call on Dec. 8, 2014 investment picks
http://media.marketwire.com/attachments/200506/213194_PSMT-blue-band.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1161975&ProfileId=051205&sourceType=1 SAN DIEGO, CA --
Sign-up for PriceSmart Announces Opening of a New Warehouse Club in Colombia investment picks
PHILADELPHIA , Oct.
Sign-up for PREIT Responds to Land and Buildings' Letter investment picks
NORFOLK, Va., Nov.
Sign-up for PRA Group Reports Third Quarter 2014 Results investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced positive results from CheckMate -037, a Phase 3 randomized, controlled open-label study of Opdivo (nivolumab), an investigational PD-1 immune checkpoint inhibitor, versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously treated with Yervoy (ipilimumab). Based on a planned interim analysis of the co-primary endpoint, the objective response rate (ORR) was 32% (95% CI = 24, 41) in the Opdivo arm (n=120) and 11% (95% CI = 4, 23) in the ICC reference arm (n=47) in patients with at least six months of follow up.
Sign-up for Positive Phase 3 Data for Opdivo (nivolumab) in Advanced Melanoma Patients Previously Treated with Yervoy (ipilimumab) Presented at the ESMO 2014 Congress; First Phase 3 Results Presented for a PD-1 Immune Checkpoint Inhibitor investment picks
SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for Portola Pharmaceuticals Announces Upcoming Presentations at the American Society of Hematology 2014 Annual Meeting investment picks
SOUTH SAN FRANCISCO, Calif., Oct.
Sign-up for Portola Pharmaceuticals Announces Commercial Supply Agreement for Andexanet Alfa With Lonza investment picks
Lackluster Derivative Demand, Falling Crude and Naphtha Prices LONDON , Oct.
Sign-up for Platts: Global Petrochemical Prices Fell 3% in September investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Rayonier Appoints Douglas Long as Vice President of U.S. Operations to Platts: Global Petrochemical Prices Fell 3% in September
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent